跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,583 条关于
“Zhejiang Jiuzhou Pharmaceutical”
全部
13,583
临床试验
600
药物
1,848
机构
2,220
资讯
8,915
2个月前
BeiGene Raises 2026 Revenue Guidance as Brukinsa Sales Momentum Continues, CEA ADC Data Slated for ESMO 2026
去年
JiuZhou Pharma Wins China Patent Excellence Award for Breakthrough Synthesis Technology
10个月前
Yangli Pharmaceutical Raises 100 Million Yuan Series B to Advance Anti-Tumor and Chronic Disease Pipeline
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
11个月前
Pacira BioSciences Faces Generic Challenge as WhiteOak Files ANDA for EXPAREL
去年
Fapon Biopharma Enrolls First Patient in Phase I Trial of FP008, Novel Anti-PD-1 Fusion Protein for Solid Tumors
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Global Clinical Trials Review of Zollinger-Ellison Syndrome (Gastrinoma) Released
去年
Algernon Pharmaceuticals Secures European Patent for Repirinast in Kidney Disease Treatment
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
第 1 页，共 892 页
上一页
下一页
